124 related articles for article (PubMed ID: 9838875)
1. A primate model of respiratory syncytial virus infection.
Babu PG; Selvan A; Christuraj S; David J; John TJ; Simoes EA
Indian J Exp Biol; 1998 Aug; 36(8):758-62. PubMed ID: 9838875
[TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.
Ponnuraj EM; Springer J; Hayward AR; Wilson H; Simoes EA
J Infect Dis; 2003 Apr; 187(8):1257-63. PubMed ID: 12696005
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata.
Simoes EA; Hayward AR; Ponnuraj EM; Straumanis JP; Stenmark KR; Wilson HL; Babu PG
Pediatr Dev Pathol; 1999; 2(4):316-26. PubMed ID: 10347274
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus persistence: evidence in the mouse model.
Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
[TBL] [Abstract][Full Text] [Related]
6. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease.
Eick A; Karron R; Shaw J; Thumar B; Reid R; Santosham M; O'Brien KL
Pediatr Infect Dis J; 2008 Mar; 27(3):207-12. PubMed ID: 18277934
[TBL] [Abstract][Full Text] [Related]
7. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys.
Koff WC; Caplan FR; Case S; Halstead SB
Clin Exp Immunol; 1983 Aug; 53(2):272-80. PubMed ID: 6883807
[TBL] [Abstract][Full Text] [Related]
9. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice.
Domachowske JB; Bonville CA; Gao JL; Murphy PM; Easton AJ; Rosenberg HF
Cell Immunol; 2000 Nov; 206(1):1-6. PubMed ID: 11161432
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
Colasurdo GN; Fullmer JJ; Elidemir O; Atkins C; Khan AM; Stark JM
J Med Virol; 2006 May; 78(5):651-8. PubMed ID: 16555274
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics.
Moore ML; Peebles RS
Pharmacol Ther; 2006 Nov; 112(2):405-24. PubMed ID: 16820210
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study.
Nielsen HE; Siersma V; Andersen S; Gahrn-Hansen B; Mordhorst CH; Nørgaard-Pedersen B; Røder B; Sørensen TL; Temme R; Vestergaard BF
Acta Paediatr; 2003 Nov; 92(11):1314-21. PubMed ID: 14696852
[TBL] [Abstract][Full Text] [Related]
14. Role of complement in neutralization of respiratory syncytial virus.
Yoder SM; Zhu Y; Ikizler MR; Wright PF
J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
[TBL] [Abstract][Full Text] [Related]
16. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization.
Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF
J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931
[TBL] [Abstract][Full Text] [Related]
17. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
Walsh EE; Falsey AR
J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
[TBL] [Abstract][Full Text] [Related]
18. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
Graham BS; Davis TH; Tang YW; Gruber WC
Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
[TBL] [Abstract][Full Text] [Related]
19. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
